Public annual accounts

Dr Tessa Mortelmans financials

Name: Dr Tessa Mortelmans financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for Dr Tessa Mortelmans, with comparable measures and links to available source documents.

Company overview

Registry number

0732977728

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for Dr Tessa Mortelmans

2025 versus 2024

Operating line: €62,710
EBITDA: €62,406
Total assets: €55,075
Equity: €47,102

EBITDA margin +99.5% · Equity ratio +85.5%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€62,710	€62,406	€55,075	€47,102	-
202431 Dec 2024	€29,739	€29,621	€96,056	€89,277	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report